MedTrace Logo

Lornoxicam Versus Etoricoxib in Postoperative Pain After Total Knee Arthroplasty

NCT02750917 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-04-26

No results posted yet for this study

Summary

The purpose of this study is to assess efficacy and safety of lornoxicam compared with that of etoricoxib after total knee replacement.

Conditions

  • Postoperative Pain

Interventions

DRUG

Lornoxicam

At the end of surgery patients in group LORNOXICAM received one pill of 8 mg lornoxicam every 12 hours in the surgery day and first postoperative day.

DRUG

Etoricoxib

At the end of surgery patients in the ETORICOXIB group received one pill of 120 mg etoricoxib at the end of surgery and a second one after 24 hours. This group also received placebo pills at 12 h, between the active pills.

Sponsors & Collaborators

  • Foisor Orthopedics Clinical Hospital

    lead OTHER

Principal Investigators

  • Ioan Cristian Stoica, Prof · Foisor Orthopedics Clinical Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-01-31
Completion
2015-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02750917 on ClinicalTrials.gov